Soleno Therapeutics, Inc. Common Stock (SLNO) Stock Price

SLNOStock
$0.00+2548.62%52W
Market Cap
P/E132.26x
PEG Ratio
Div yield
Beta1.78

SLNO Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)6.07%
Price vs S&P 500 (4W)-4.30%
VGM Score72.32
P/E Ratio (Annual)132.26x

SLNO Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
2.69
2.69
2.69
2.69

Industry Peers — Pharmaceuticals(570)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
SLNOSoleno Therapeutics, Inc. Common Stock
DAA$0.00
LLYEli Lilly & Co.DBC$1174.61
JNJJohnson & JohnsonDCB$268.04
ABBVABBVIE INC.DCB$255.48
MRKMerck & Co., Inc.DCB$148.35
NVSNovartis AGCCC$153.81
AZNAstraZeneca PLCCBC$162.70
NVONovo-Nordisk A/SBCC$45.61
ABTAbbott LaboratoriesCCC$112.47
PFEPfizer Inc.CDB$27.96
VRTXVertex Pharmaceuticals IncDCB$541.69

About Soleno Therapeutics, Inc. Common Stock

Soleno Therapeutics is a biopharmaceutical company developing novel treatments for rare diseases. Its lead product candidate, DCCR (Diazoxide Choline), is a proprietary extended-release formulation designed to activate KATP channels in the brain, pancreas, and fat tissue. The company targets underserved patient populations with significant unmet medical needs.